INDIGO Biosciences, Inc. (INDIGO) is a leading provider of nuclear receptor and in vitro toxicology solutions that accelerates scientific decision-making. We supplement the world's largest portfolio of nuclear receptor kits and services and in vitro toxicology solutions with greater results readability, reproducibility, accuracy, and turnaround times. Our solutions, plus supportive team and reliable science and platforms aims to reduce time, cost, and risk associated with the discovery process.